Cargando…
Oral bisphosphonate compliance and persistence: a matter of choice?
Compliance to oral bisphosphonates is suboptimal, with negative consequences of increased healthcare utilization and less effective fracture risk reduction. Extending dose interval increased adherence only moderately. We used literature derived from multiple chronic conditions to examine the problem...
Autores principales: | Silverman, S. L., Schousboe, J. T., Gold, D. T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017316/ https://www.ncbi.nlm.nih.gov/pubmed/20458571 http://dx.doi.org/10.1007/s00198-010-1274-6 |
Ejemplares similares
-
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017) -
Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019) -
Compliance and persistence with osteoporosis medications: A critical review of the literature
por: Silverman, Stuart, et al.
Publicado: (2010) -
The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review
por: Adachi, Jonathan, et al.
Publicado: (2007) -
Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern
por: Ko, Kyung Rae, et al.
Publicado: (2020)